Close Menu

Books in a Library

Anaplastic lymphoma kinase mutation

Identification of Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Gene Rearrangement in Lung Adenocarcinomas

DOI: 
10.7727/wimj.2018.065
Synopsis: 
The identification of molecular alterations has an important therapeutic implication in patients with lung adenocarcinomas. In this study, we presented our experience with the identification of EGFR and ALK mutations using tissue specimens of primary and metastatic lung adenocarcinomas.

ABSTRACT

Objective: The identification of molecular alterations has an important therapeutic implication in lung adenocarcinoma patients. Herein, we presented our experience with the identification of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase(ALK) mutations in primary and metastatic lung adenocarcinomas.

Accepted: 
08 May, 2018
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 15 Feb, 2019

Disclaimer

Manuscripts that are “Published at Acceptance” have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear prior to being copy edited or formatted in the style guide of this Journal. The contents of the manuscript may change before it is published in its final form. While accepted manuscripts are not yet assigned a volume, issue, or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. Manuscripts in this section will be removed once they have been assigned to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - Anaplastic lymphoma kinase mutation
Top of Page